Search
for
Sort by
Research 331–360 of 765
- CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS FROM A TERTIARY CARE CENTRE IN COASTAL KERALA
- A Case of Azathioprine Induced Severe Myelosuppression and Alopecia Totalis in IgA Nephropathy
- TOC
- Post-steroid panniculitis: a lost and forgotten entity?
- BOOK REVIEWS
- PC039: Adverse effects at the level of marginal periodontium secondary to Finasteride administration
- Alopecia Areata: A tissue specific autoimmune disease of the hair follicle
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Madarosis
- Innovative Uses for Zinc in Dermatology
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- The spectrum of nephrocutaneous diseases and associations
- Erythematous cutaneous nodules caused by adulterated cocaine
- Innervated Biomaterials for Improved Cutaneous Wound Healing: A Review of Recent Advancements and Future Prospects
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Overexpression of HE4/WFDC2 gene in mice leads to keratitis and corneal opacity
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Dermatological Manifestations of COVID-19: A Brief Review
- Clinical Management in Psychodermatology
- National scientific medical meeting 1996 abstracts
- Westwood Carolina Conference on Clinical Dermatology
- Severe cutaneous adverse reactions to drugs
- Cutaneous signs in COVID ‐19 patients: A review
- The pharmacology of methotrexate
- Clinical manifestations of cutaneous lupus erythematosus
- Obesity and the skin
- Primary cicatricial alopecia